In Wake Of Guidant Woes, HRS To Create ICD Safety Alert Guidelines
This article was originally published in The Gray Sheet
Executive Summary
The Heart Rhythm Society's Task Force on Device Performance will hold a public meeting in the fall to finalize guidelines on how ICD manufacturers should report potential device safety problems to physicians
You may also be interested in...
“Passive” Adverse Event Data Inadequate, Say FDA/HRS Meeting Panelists
FDA must expand its "enhanced" adverse event reporting system and improve "passive" surveillance in order to detect rare device malfunctions, said panelists at the Policy Conference on Pacemaker and Implantable Cardioverter Defibrillator Performance in Washington, D.C. Sept. 16
“Passive” Adverse Event Data Inadequate, Say FDA/HRS Meeting Panelists
FDA must expand its "enhanced" adverse event reporting system and improve "passive" surveillance in order to detect rare device malfunctions, said panelists at the Policy Conference on Pacemaker and Implantable Cardioverter Defibrillator Performance in Washington, D.C. Sept. 16
Independent Panel Study Of Guidant Will Help Beyond ICDs – Panel Chair
An independent panel created by Guidant will produce a case study on the company's recent handling of implantable cardioverter defibrillator safety communications by February 2006, according to panel chair Robert Myerburg, MD, University of Miami